Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Preclinical Imaging Global Market Report 2025
Download Free Sample Buy Now
Global Preclinical Imaging Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Preclinical Imaging Global Market Report 2025

By Modality (Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems), By Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents ), By End User (Hospital, Diagnostics Center, Other End-User) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Preclinical Imaging Market Overview

• Preclinical Imaging market size has reached to $3.46 billion in 2024

• Expected to grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%

• Growth Driver: Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth

• Market Trend: Revolutionizing Preclinical Imaging Through Cutting-Edge Technology And Flexibility

• North America was the largest region in 2024.

What Is Covered Under Preclinical Imaging Market?

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

The main types of modalities in preclinical imaging are optical imaging systems, preclinical nuclear imaging systems, micro-magnetic resonance imaging systems, micro-ultrasound systems, micro-computed tomography systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems. Optical imaging systems refer to a range of imaging technologies that utilize light to visualize and capture images of biological tissues, cells, or molecules. Optical imaging systems are employed in the preclinical phase of imaging for research, illness diagnostics, tumor blood vessel growth monitoring, and tissue blood oxygenation tracking in animals. It includes various reagents such as preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents and preclinical CT contrast agents. The main end-users are hospitals, diagnostic centers, and others.

Preclinical Imaging Market Size and growth rate 2025 to 2029: Graph

What Is The Preclinical Imaging Market Size 2025 And Growth Rate?

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.46 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to government initiatives, the growing prevalence of diseases, expanding applications, increasing awareness, and emerging markets expansion

What Is The Preclinical Imaging Market Growth Forecast?

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, and rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, a rise in R&D activities, collaborations and partnerships, and real-time imaging.

The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. research capabilities by inflating prices of high-resolution micro-CT scanners and Positron Emission Tomography-Magnetic Resonance Imaging systems(PET-MRI systems) manufactured in Japan and Switzerland, resulting in reduced imaging throughput and higher academic lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Preclinical Imaging Market Segmented?

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

What Is Driving The Preclinical Imaging Market? Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth

The increase in chronic diseases is expected to propel the growth of the preclinical imaging market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. These diseases often require ongoing medical management and can significantly impact a person's quality of life. For identifying chronic diseases, preclinical imaging tools are used for visualizing the bone structure and lung function. It is also used to study chronic diseases to visualize the progression of the disease and improve disease understanding. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by Noncommunicable diseases (NCDs) or chronic diseases every year globally. Among them are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, increasing chronic disease is driving the growth of the preclinical imaging industry.

What Is Driving The Preclinical Imaging Market? Pharmaceutical Boom Fuels Preclinical Imaging Market Growth

Rising demand for pharmaceutical products is expected to propel the growth of the preclinical imaging market going forward. Pharmaceutical products refer to substances or compounds formulated and manufactured to prevent, diagnose, or treat medical conditions. Preclinical imaging in the pharmaceutical industry enhances decision-making by providing valuable insights into drug efficacy, safety, and mechanisms of action before advancing to clinical trials. For instance, in April 2023, according to Eurostat, a Luxembourg-based government agency, exports of medicinal and pharmaceutical products increased to $307 billion (€287) billion in 2022, an increase of 22% from a year earlier. Additionally, imports rose from $107 billion (€100 billion) in 2021 to $120 billion (€112 billion) in 2022. Furthermore, in February 2023, according to the Merck Group, a Germany-based pharmaceutical company, pharmaceutical product sales for the year 2022 accounted for $59.3 billion, a 22% increase over the full year 2021. Therefore, rising demand for pharmaceutical products is driving the growth of the preclinical imaging industry.

Who Are The Major Players In The Global Preclinical Imaging Market?

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

What Are The Key Trends Of The Global Preclinical Imaging Market? Revolutionizing Preclinical Imaging Through Cutting-Edge Technology And Flexibility

Product innovations are a key trend gaining popularity in the preclinical imaging market. Major companies operating in the preclinical imaging market are developing innovative products to sustain their position in the market. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical company that manufactures imaging systems, launched Vevo F2 for preclinical imaging. This innovative product is the first preclinical ultra-high- to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging system. The Vevo F2 features HD image processing technology and a completely new signal pathway, enabling better image clarity and better frame rates. The system is also customizable to fit the specific precision demands of imaging. Additionally, it includes features such as HD image processing technology, a completely new signal pathway, customizable system architecture, a wide range of anatomical targets, and high-resolution imaging. It is suitable for a variety of research applications.

What Are The Key Trends Of The Global Preclinical Imaging Market? Next-Generation Imaging Systems For Enhanced Capabilities And Workflow Efficiency

Major companies operating in the preclinical imaging market are increasing their focus on introducing next-generation imaging systems to gain a competitive edge in the market. Next-generation imaging systems refer to advanced and innovative technologies that go beyond current capabilities, incorporating cutting-edge features. For instance, in September 2023, Revvity Inc., a US-based biotechnology company, launched next-generation imaging systems that are designed to drive innovation across diverse applications in preclinical research. The newly launched products include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that seamlessly integrates 2D optical and full 3D imaging. These imaging systems feature improved image-based capabilities and are designed to streamline the imaging workflow.

Need data on a specific region in this market?
Request Regional Data

Preclinical Imaging Market Merger And Acquisition: Bruker Acquires Spectral Instruments Imaging To Strengthen Life Sciences Capabilities

In February 2024, Bruker Corporation, a USA-based Medical Devices, acquired Spectral Instruments Imaging (SII) for a $37.5million. this acquisition reflects, Bruker's commitment to advancing scientific research and improving its technological capabilities in the life sciences sector.Spectral Instruments Imaging (SII) is a US-based manufactures Preclinical Optical systems for bioluminescent, fluorescent and x-ray imaging.

Regional Outlook For The Global Preclinical Imaging Market

North America was the largest region in the preclinical imaging market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Preclinical Imaging Market?

The preclinical imaging market includes of revenues earned by entities by providing preclinical imaging services such as magnetic resonance imaging, positron emission tomography, computed tomography, and optical imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Preclinical Imaging Industry?

The preclinical imaging market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical imaging industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Preclinical Imaging Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $3.69 billion
Revenue Forecast In 2034 $4.81 billion
Growth Rate CAGR of 6.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User Subsegments: 1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems 6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems 7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Preclinical Imaging Market Characteristics

3. Preclinical Imaging Market Trends And Strategies

4. Preclinical Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Preclinical Imaging Growth Analysis And Strategic Analysis Framework

5.1. Global Preclinical Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Preclinical Imaging Market Growth Rate Analysis

5.4. Global Preclinical Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Preclinical Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Preclinical Imaging Total Addressable Market (TAM)

6. Preclinical Imaging Market Segmentation

6.1. Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Optical Imaging Systems

Preclinical Nuclear Imaging Systems

Micro-magnetic Resonance Imaging Systems

Micro-Ultrasound Systems

Micro-computed Tomography Systems

Preclinical Photoacoustic Imaging Systems

Preclinical Magnetic Particle Imaging (MPI) Systems

6.2. Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical Optical Imaging Reagents

Preclinical Nuclear Imaging Reagents

Preclinical MRI Contrast Agents

Preclinical Ultrasound Contrast Agents

Preclinical CT Contrast Agents

6.3. Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Diagnostics Center

Other End-User

6.4. Global Preclinical Imaging Market, Sub-Segmentation Of Optical Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bioluminescence Imaging

Fluorescence Imaging

6.5. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Nuclear Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Positron Emission Tomography (PET)

Single-Photon Emission Computed Tomography (SPECT)

6.6. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Magnetic Resonance Imaging (Micro-MRI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Resolution Micro-MRI Systems

Functional Micro-MRI Systems

6.7. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Ultrasound Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Frequency Ultrasound Imaging

Real-Time Micro-Ultrasound Systems

6.8. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Computed Tomography (Micro-CT) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In Vivo Micro-CT Systems

Ex Vivo Micro-CT Systems

6.9. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Photoacoustic Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Multi-Wavelength Photoacoustic Imaging

Hybrid Photoacoustic Imaging Systems

6.10. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Magnetic Particle Imaging (MPI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

MPI For Cell Tracking

MPI For Vascular Imaging

7. Preclinical Imaging Market Regional And Country Analysis

7.1. Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preclinical Imaging Market

8.1. Asia-Pacific Preclinical Imaging Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Preclinical Imaging Market

9.1. China Preclinical Imaging Market Overview

9.2. China Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Preclinical Imaging Market

10.1. India Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Preclinical Imaging Market

11.1. Japan Preclinical Imaging Market Overview

11.2. Japan Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Preclinical Imaging Market

12.1. Australia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Preclinical Imaging Market

13.1. Indonesia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Preclinical Imaging Market

14.1. South Korea Preclinical Imaging Market Overview

14.2. South Korea Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Preclinical Imaging Market

15.1. Western Europe Preclinical Imaging Market Overview

15.2. Western Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Preclinical Imaging Market

16.1. UK Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Preclinical Imaging Market

17.1. Germany Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Preclinical Imaging Market

18.1. France Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Preclinical Imaging Market

19.1. Italy Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Preclinical Imaging Market

20.1. Spain Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Preclinical Imaging Market

21.1. Eastern Europe Preclinical Imaging Market Overview

21.2. Eastern Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Preclinical Imaging Market

22.1. Russia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Preclinical Imaging Market

23.1. North America Preclinical Imaging Market Overview

23.2. North America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Preclinical Imaging Market

24.1. USA Preclinical Imaging Market Overview

24.2. USA Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Preclinical Imaging Market

25.1. Canada Preclinical Imaging Market Overview

25.2. Canada Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Preclinical Imaging Market

26.1. South America Preclinical Imaging Market Overview

26.2. South America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Preclinical Imaging Market

27.1. Brazil Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Preclinical Imaging Market

28.1. Middle East Preclinical Imaging Market Overview

28.2. Middle East Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Preclinical Imaging Market

29.1. Africa Preclinical Imaging Market Overview

29.2. Africa Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Preclinical Imaging Market Competitive Landscape And Company Profiles

30.1. Preclinical Imaging Market Competitive Landscape

30.2. Preclinical Imaging Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. FUJIFILM Visualsonics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Preclinical Imaging Market Other Major And Innovative Companies

31.1. Bio-Rad Laboratories Inc.

31.2. Bruker Corporation

31.3. Miltenyi Biotech

31.4. Sofie Biosciences Inc.

31.5. Promega Corporation

31.6. Ion Beam Applications S.A

31.7. Nihon Kohden

31.8. Piramal Enterprises Ltd

31.9. LI-COR Biosciences Inc.

31.10. Aspect Imaging Ltd

31.11. Capintec Inc.

31.12. Spectral Instruments Inc.

31.13. Mediso Ltd

31.14. MR Solutions Ltd

31.15. Biospace Lab S. A.

32. Global Preclinical Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preclinical Imaging Market

34. Recent Developments In The Preclinical Imaging Market

35. Preclinical Imaging Market High Potential Countries, Segments and Strategies

35.1 Preclinical Imaging Market In 2029 - Countries Offering Most New Opportunities

35.2 Preclinical Imaging Market In 2029 - Segments Offering Most New Opportunities

35.3 Preclinical Imaging Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Preclinical Imaging Market, Sub-Segmentation Of Optical Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Nuclear Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Magnetic Resonance Imaging (Micro-MRI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Ultrasound Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Computed Tomography (Micro-CT) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Photoacoustic Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Magnetic Particle Imaging (MPI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: FUJIFILM Visualsonics Inc. Financial Performance
  • Table 83: Konica Minolta Inc. Financial Performance
  • Table 84: Agilent Technologies Inc. Financial Performance
  • Table 85: PerkinElmer Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Preclinical Imaging Market, Sub-Segmentation Of Optical Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Nuclear Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Magnetic Resonance Imaging (Micro-MRI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Ultrasound Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Computed Tomography (Micro-CT) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Photoacoustic Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Magnetic Particle Imaging (MPI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: FUJIFILM Visualsonics Inc. Financial Performance
  • Figure 83: Konica Minolta Inc. Financial Performance
  • Figure 84: Agilent Technologies Inc. Financial Performance
  • Figure 85: PerkinElmer Inc. Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Preclinical Imaging Global Market Report 2025 – By Modality (Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Sys...

View Report

Medical Imaging Global Market Report 2025 – By Product (X-Ray Devices, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography, Nuclear Imaging, Mammography), By Application (Obstetrics And Gynecology Health, O...

View Report

Pediatric Imaging Global Market Report 2025 – By Modality (Ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), X-ray, Other Modalities), By Application (Orthopedics, Gastroenterology, Cardiology, Onco...

View Report

Clinical Trial Imaging Global Market Report 2025 – By Product And Services (Services, Software), By Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomogra...

View Report

Small Animal Imaging (In-Vivo) Global Market Report 2025 – By Component (Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components), By Application (Monitoring Treatment Response, Bio Distribution, Determining Drug o...

View Report

Optical Imaging Global Market Report 2025 – By Product( Imaging Systems, Cameras, Software, Other Products), By Application( Pathological Imaging, Intra-operative Imaging), By End-User( Hospitals & Clinics, Research Labo...

View Report

Intraoperative Imaging Global Market Report 2025 – By Product (Intraoperative Ultrasound System, Intraoperative Computed Tomography System, C-Arms System, Intraoperative Magnetic Resonance Imaging Systems, Other Products...

View Report

POC Medical Imaging Global Market Report 2025 – By Product (X-Ray, CT, Ultrasound), By Application (Cardiology, Gynecology Or Obstetrics, Oncology, Orthopedics, Neurology, Other Applications), By End-User (Hospitals, Cli...

View Report

Frequently Asked Questions

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases. For further insights on this market, request a sample here

The market major growth driver - Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth. For further insights on this market, request a sample here

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.46 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to government initiatives, the growing prevalence of diseases, expanding applications, increasing awareness, and emerging markets expansion. The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to " $4.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, and rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, a rise in R&D activities, collaborations and partnerships, and real-time imaging. For further insights on this market, request a sample here

The preclinical imagingmarket covered in this report is segmented –
1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents
3) By End User: Hospital; Diagnostics Center; Other End-User Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging For further insights on this market, request a sample here

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics. . For further insights on this market, request a sample here.

Major trends in this market include Revolutionizing Preclinical Imaging Through Cutting-Edge Technology And Flexibility. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Preclinical Imaging Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon